Screening and Detection Tests for Alzheimer's Disease: The Benefits and Costs

Dr. Douglas Scharre talks about methods used for early detection of Alzheimer’s Disease, and their respective advantages vs costs in clinical practice
  • Overview

    Dr. Douglas Scharre, Professor of Clinical Neurology and Psychiatry with the Center for Cognitive and Memory Disorder at The Ohio State University Wexner Medical Center, speaks to the methods used for early detection of Alzheimer’s Disease, and their respective advantages vs costs in clinical practice.

     

    Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection, sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Sign-up for the Global Neurology Academy newsletters.
Comprehensive Neurology Education.

Better education for a better you.

* Required
Optional